Kenneth C. Griffin | sciencenewsnet.in

Breaking News

Nonmotor Seizures May Be Missed in Children, Teens

CHOP Researchers Identify Causal Genetic Variant Linked to Common Childhood Obesity

Study: Hillocks challenge our understanding of lung biology

Register for Food and Nutrition Institute’s Fourth Annual Conference on Science, Regulation

Mayo Clinic Laboratories and Progentec Diagnostics launch lupus advanced biomarker testing services

May is Mental Health Awareness Month

Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute

Plant-LncPipe: a new tool for plant long non-coding RNA (lncRNA) identification

New findings point to an Earth-like environment on ancient Mars

At the Climate READi workshop: Resilient power systems in the context of climate change

02 May, 2024

Sylvester Cancer Tip Sheet for March 2024

March 19, 2024 sarah JonasFeature

A transformative gift to expand research and breakthrough therapies, an upcoming conference on managing neuroendocrine tumors, FDA approval of Imetelstat for patients with anemia from myelodysplastic syndromes and a researcher advocating for making bereavement care a public health priority are all included in this month’s tip sheet from Sylvester Comprehensive Cancer Center.

University of Miami’s Sylvester Comprehensive Cancer Center Announces Transformational Gift From Kenneth C. Griffin

March 5, 2024 sarah JonasAnnouncement

The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.